Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.3, 2008-03, pp. : 367-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!

By Stintzing Sebastian Lenz Heinz-Josef

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2203-2220

Informa Healthcare

Access to resources Recommend Favorite

Panitumumab: In the Treatment of Metastatic Colorectal Cancer

By Hoy Sheridan M. Wagstaff Antona J.

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 2005-2014

Adis International

Access to resources Recommend Favorite

Cetuximab: In the Treatment of Metastatic Colorectal Cancer

By Reynolds N.A. Wagstaff A.J.

Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. : 109-118

Adis International

Access to resources Recommend Favorite

Death associated protein kinase as a potential therapeutic target

By Schumacher Andrew M Velentza Anastasia V Watterson D Martin

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 4, 2002-08 ,pp. : 497-506

Informa Healthcare

Access to resources Recommend Favorite

Metastatic Colorectal Cancer: Current Systemic Treatment Options

By Board Ruth E. Valle Juan W.

Drugs, Vol. 67, Iss. 13, 2007-01 ,pp. : 1851-1867

Adis International

Access to resources Recommend Favorite